Company
Soligenix Inc
NASDAQ:SNGX
Soligenix, Inc. is a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company has two areas of focus:
6 stories
Soligenix must enroll more people in Phase 3 test to treat lymphoma, prompting shares to tumble
Company said it has sufficient funds to fund the additional study
Hardware & electrical equipment
Small-Cap Snapshot: Krystal Biotech shares pop on optimistic early results from new gene therapy treatment
Soligenix, SELLAS Life Sciences Group, AcelRx, WeedMD, Arcadia Biosciences and Security Devices International are also moving in the trading session